用可转换的CAR-T细胞攻击潜伏的HIV, 这是一种高度适应的杀伤平台
Eytan Herzig1, Kaman Chan Kim2, Thomas A Packard1
1Gladstone Center for HIV Cure Research, Gladstone Institute of Virology and Immunology, San Francisco, CA 94158, USA; Departments of Medicine and Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.
Cell
|November 1, 2019
概括
一个新的可转换的CAR-T细胞平台有效地向并消除感染艾滋病毒的细胞,包括潜伏的艾滋病毒储存器. 通过增强对病毒的免疫反应, 这种创新方法为消除艾滋病毒提供了有希望的策略.
科学领域:
- 免疫学
- 病毒学
- 细胞治疗
背景情况:
- 减少潜伏的艾滋病毒储存量对于消除艾滋病毒至关重要.
- 目前的方法依赖于重新激活,然后消除受感染的细胞.
- 内源性细胞毒性T淋巴细胞 (CTL) 由于耗尽和病毒逃逸而在清除储存器方面存在限制.
研究的目的:
- 设计和评估一个针对潜伏HIV的通用CAR-T细胞平台.
- 评估具有广泛中和抗艾滋病毒抗体的工程CTL的有效性.
主要方法:
- 使用工程 CTL 开发可转换的 CAR-T 电池平台.
- 测试可转换的CAR-T细胞杀死来自各种组织 (血液,桃体,脏) 的CD4T细胞的能力.
- 评估在接受抗逆转录病毒治疗的HIV感染者的细胞中诱导性HIV储存物的杀死.
主要成果:
- 可转换的CAR- T细胞有效地杀死了感染HIV的CD4T细胞,但没有杀死未感染的细胞,当它们被抗HIV抗体武装时.
- 该平台在48小时内在受治疗的个体的细胞中减少了可诱导的HIV储存.
- 模块化可以与多个抗体进行多重复合,增强范围和控制.
结论:
- 这种可转换的CAR-T细胞平台是攻击潜伏HIV储存的有希望的工具.
- 这种工程T细胞疗法显示出更有效的HIV治疗策略的潜力.
- 模块化设计提供了灵活性和更好的控制针对HIV感染细胞.
更多相关视频
相关概念视频
Retrovirus Life Cycles
49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Size and Structure of Viral Genomes
598
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
598
Immune Response Against Viral Pathogens
1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


